Search - tctmd.com

Displaying 141 - 160 of 433

Sort: Relevancy | Date

News Industry News

Assessing Fractional Flow Reserve Using Computed Tomography Shown To Reduce Costs in Patients With Chest Pain

October 13, 2015

News Daily News

Stroke Risk of Carotid Occlusion Appears Very Low in Contemporary Asymptomatic Patients

September 29, 2015

News Daily News

Study Hints That Many ICU Admissions for Acute MI Patients May Be Unnecessary

Todd Neale

September 28, 2015

News Daily News

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

L.A. McKeown

September 28, 2015

News Industry News

Advanced Catheter Therapies Receives Second FDA 510(k) Clearance on Occlusion Perfusion Catheter

September 24, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Daily News

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

L.A. McKeown

September 09, 2015

News Conference News ESC 2015

FREEDOM Substudy: CABG, PCI Outcomes Affected by Baseline BP

Yael L. Maxwell

August 30, 2015

News Industry News

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

August 26, 2015

News Daily News

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

Todd Neale

August 17, 2015

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Industry News

Doctor's Best Introduces Two New Heart Health Supplements

August 11, 2015

News Industry News

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

August 10, 2015

News Industry News

Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension

July 28, 2015

News Industry News

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

July 20, 2015

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

News Industry News

Cardiovascular Systems Completes Coast Study Enrollment

July 14, 2015

News Daily News

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Yael L. Maxwell

July 10, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

Advertisement

Assessing Fractional Flow Reserve Using Computed Tomography Shown To Reduce Costs in Patients With Chest Pain

Stroke Risk of Carotid Occlusion Appears Very Low in Contemporary Asymptomatic Patients

Study Hints That Many ICU Admissions for Acute MI Patients May Be Unnecessary

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

Advanced Catheter Therapies Receives Second FDA 510(k) Clearance on Occlusion Perfusion Catheter

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

FREEDOM Substudy: CABG, PCI Outcomes Affected by Baseline BP

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Doctor's Best Introduces Two New Heart Health Supplements

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

Cardiovascular Systems Completes Coast Study Enrollment

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content